Please do not adjust margins
New Journal of Chemistry
Page 4 of 5
DOI: 10.1039/C8NJ03478H
COMMUNICATION
Journal Name
13 R. K. Yadav, G. H.Oh, N.-J. Park, A. Kumar, K.-J. Kong and J.-O.
Baeg, J. Am. Chem. Soc., 2014, 136, 16728.
14 S. Gao, Y. Lin, X. Jiao, Y. Sun, Q. Luo, W. Zhang, D. Li, J. Yang
and Y. Xie, Nature 2016, 529, 69.
15 S. Sen, D. Liu, and G. T. R. Palmore, ACS Catal., 2014, 3, 3091.
16 Y. Huang, A. D. Handoko, P. Hirunhit and B. S. Yeo, ACS Catal.,
2017, 7, 1749.
17 Y. Wang, M. Li, Z. Zhao and W. Liu, J. Mol. Catal. B: Enzym.,
2015, 116, 89.
18 Y. Amao, S. Takahara and Y. Sakai, Int. J. Hydrog. Energ.,
2014, 39, 20771.
19 Y. Amao, N. Shuto, K. Furuno, A. Obata,Y. Fuchino, K.
Uemura, T. Kajino, T. Sekito, S. Iwai, Y. Miyamoto and M.
Matsuda, Faraday Discuss., 2012, 155, 289.
His 311 are located and these amino-residues directly act on
the CO2 reduction and fomric acid oxidation. It is reported that
sodium azide, which is an inhibitor of formic acid or CO2, is
bonded to the CO2 or formic acid binding site of FDH.46 The
catalytic activities of the CO2 reduction and fomric acid
oxidation of FDH are inhibited with excess sodium azide. As
shown in Fig. 4, methylpyridinium-moiety of CMV· closed to
the CO2 or formic acid binding site of FDH. As the
methylpyridinium-moiety of CMV· also is bonded to the CO2 or
formic acid binding site of FDH under the higher CMV·
concentrations, CMV· acts as an inhibitor in the CO2 reduction
with FDH. Therefore, it is predicted that the approach of CO2
to the CO2 or formic acid binding site of FDH was hindered by
the methylpyridinium-moiety of CMV· under the higher CMV·
concentrations.
20 R. Miyatani and Y. Amao, J. Mol. Catal. B: Enzym., 2004, 27
121.
,
21 H. Inoue, M. Yamachika and H. Yoneyama, J. Chem. Soc.,
Faraday Trans., 1992, 88, 2215.
22 T. W. Woolerton, , S. Sheard, , E. Reisner, , E. Pierce, S. W.
Through this study, we found that carbamoyl-group was a
suitable functional group to increase the affinity of BP· with
FDH and the CO2 reduction catalytic efficiency of FDH was
improved by using CMV·. In addition, the abnormal co-
enzymatic behaviour of BP· on the CO2 reduction catalytic
activity of FDH newly was discovered. The enhancement and
deactivation behaviour of CMV· on the CO2 reduction catalytic
activity of FDH can be switched with the concentration of CMV·
in the sample solution.
Ragsdale and F. A. Armstrong, J. Am. Chem. Soc., 2010, 132
2132.
,
23 Y. Amao S. Ikeyama, T. Katagiri and K. Fujita, Faraday
Discuss., 2017, 198, 73.
24 T. Katagiri, S. Ikeyama and Y. Amao, J. Photochem. Photobiol.
A. Chem., 2018, 358, 368.
25 S. Bajracharya, S. Srikanth, G. Mohanakrishna, R. Zacharia,
D.P.B.T.B. Strik and D. Pant, J. Power Sources, 2017, 356
256.
,
26 Y. Amao, J. CO2 Utilization, 2018, 26, 623.
27 Y. Amao, Sustainable Energy & Fuels, 2018, 2, 1928.
28 S. Srikanth, Y. Alvarez-Gallego, K. Vanbroekhoven and
D. Pant, ChemPhysChem, 2017, 18, 3174.
29 U. Ruschic, U. Muller, P. Willnow and T. Hopner, Eur. J.
Biochem., 1970, 70, 325.
30 B. A.Parkinson and P. F. Weaver, Nature, 1984, 309, 148.
31 K. Schuchmann and V. Müller, Science, 2013, 342, 1382.
32 T. Reda, C. M. Plugge, N. J. Abram and J. Hirst, Proc. Natl.
Acad. Sci. U.S.A., 2008, 105, 1065.
Acknowledgement
This work was partially supported by Grant-in-Aid for Scientific
Research on Innovative Areas “Artificial Photosynthesis (2406)” and
“Innovations for Light-Energy Conversion (4906; 18H05174)”.
33 A. Alissandratos, H. Kim, H. Matthews, J. E. Hennessy, A.
Philbrook and C. J. Easton, Appl. Environ. Microbiol., 2013,
79, 741.
Notes and references
1
R. Kuriki, M. Yamamoto, K. Higuchi, Y. Yamamoto, M.
Akatsuka, D. Lu, S. Yagi, T. Yoshida, O. Ishitani and K. Maeda,
Angew. Chem. Int. Edit., 2017, 56, 4867.
34 M. Kodaka and Y. Kubota, J. Chem. Soc., Perkin Trans. 2,
1999,
35 D. Mandler and I. Willner, J. Chem. Soc., Perkin Trans. 2,
1988, , 997.
36 Y. Amao and S. Ikeyama, Chem. Lett., 2015, 44, 1182.
37 S. Ikeyama and Y. Amao, ChemCatChem, 2017, , 833.
4, 891.
2
3
4
5
6
7
8
T. Takayama, , K. Sato, T. Fujimura, Y. Kojima, A. Iwase and
A. Kudo, Faraday Discuss., 2017,198, 397.
H. Tatsumi,, K. Teramura, Z. Huang, Z. Wang, , H. Asakura, S.
Hosokawa and T. Tanaka, Langmuir. 2017, 33, 13929
Y. Kuwahara, Y. Fujie and H. Yamashita, ChemCatChem,
6
9
38 S. Ikeyama, R. Abe, S. Shiotani and Y. Amao, Chem. Lett.,
2016, 45, 907.
39 S. Ikeyama and Y. Amao, Chem. Lett., 2016, 45, 1259.
40 S. Ikeyama, T. Katagiri, Y.Amao, J. Photochem. Photobiol. A.
Chem., 2018, 358, 362.
41 J. S. Blanchard and W. W. Cleland, Biochem., 1980, 19, 3543.
42 B. Schiøtt, Y. J. Zheng and T. C. Bruice, J. Am. Chem. Soc.,
1998, 120, 7192.
43 A. Andreadeli, D. Platis, V. Tishkov, V. Popov and N. E.
Labrou, FEBS. J., 2008, 275, 3859.
2017, 9, 1906.
A. Anzai, N. Fukuo, A. Yamamoto and H. Yoshida, Catal.
Commun., 2017, 100, 134.
T. Umegaki, Y. Enomoto and Y. Kojima, Catal. Sci. Technol.,
2016, 6, 409.
G. A. Filonenko, W. L. Vrijburg, E. J. M. Hensen and E. A.
Pidko, J. Catal., 2016, 343, 97.
J. F. Hull, Y. Himeda,; W. H. Wang, B. Hashiguchi, R. Periana,
D. J. Szalda, J. T. Muckerman and E. Fujita, Nat. Chem., 2012,
4, 383.
44 R. Hatrongjit and K. Packdibamrung, Enzyme. Microb.
Technol., 2010, 46, 557.
45 N. E. Labrou and D. J. Rigden, Biochem. J., 2001, 354, 455.
9
K. Larmier, W. C. Liao, S. Tada, E. Lam, R. Verel, A. Bansode,
A. Urakawa and C. Copéret, Angew. Chem., 2017, 129, 2358.
10 A. V. Bavykina, E. Rozhko, M. G. Goesten, T. Wezendonk, B.
Seoane, F. Kapteijn, M. Makkee and J. Gascon,
ChemCatChem, 2016, , 2217.
11 T. W. Woolerton, S. Sheard, E. Reisner, E. Pierce, S. W.
Ragsdale and F. A. Armstrong, J. Am. Chem. Soc., 2010, 132
46 N. E. Labrou, D. J. Rigden and Y. D. Clonis, FEBS J., 2000, 267
6657.
,
8
,
2132.
12 X. D. Tong, B. El-Zahab, X. Y. Zhao, Y. Y. Liu and P. Wang,
Biotechnol. Bioeng., 2011, 108, 465.
4 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins